Search LMAT
LEMAITRE VASCULAR INC
Nasdaq · CIK 1158895
Last close78.96
Daily change-1.23 (-1.53%)
10 Years gain+322.53%
Dividends TTM0.95 (+25.00%)
Dividend yield1.18%
Fundamental Analysis
LMAT · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
64.9Momentum
n/aAcceleration
n/aConfidence
65.0Annual Revenue17
Quarterly Revenue64
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth19.4 / 25
Quality17.2 / 25
Capital Efficiency10.1 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM20.72%OK
Revenue CAGR 3Y15.58%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $249.60M | $178.54M | $67.91M | $81.25M | $74.47M | 71.53% | 27.21% | 29.83% | 144.93% | 22.93M |
| 2025 FY Dec 31, 2024 | $219.86M | $150.90M | $52.26M | $44.12M | $37.16M | 68.63% | 23.77% | 16.9% | 35.12% | 22.78M |
| 2025 FY Dec 31, 2023 | $193.48M | $127.05M | $36.71M | $36.75M | $29.49M | 65.66% | 18.97% | 15.24% | 14.8% | 22.42M |
| 2024 FY Dec 31, 2022 | $161.65M | $104.90M | $26.83M | $25.38M | $22.15M | 64.89% | 16.6% | 13.7% | 10.9% | 22.17M |
| 2023 FY Dec 31, 2021 | $154.42M | $101.38M | $36.43M | $35.10M | $30.22M | 65.65% | 23.59% | 19.57% | n/a | 21.48M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $211.56M | sum latest 4 fiscal quarters Revenue | OK | 0001437749-24-034124, 0001437749-24-015899 |
| Revenue Growth TTM | 20.72% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001437749-24-034124, 0001437749-24-015899 |
| Revenue CAGR 3Y | 15.58% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-073360 |
| Revenue CAGR 5Y | 14.05% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-073360 |
| Gross Profit CAGR 3Y | 19.4% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-073360 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001437749-24-034124 |
| Current Ratio | 7.74x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | 31.37% | Cash dividends paid / Net income | OK | 0001193125-26-073360 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001193125-26-073360 |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |
| Gross Margin Delta 3Y | n/a | GrossMargin_current - GrossMargin_3Y_ago | INSUFFICIENT_HISTORY | derived |